Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark Broadwin, MD"'
Autor:
Dwight D. Harris, MD, Sharif A. Sabe, MD, Mark Broadwin, MD, Christopher Stone, MD, Cynthia Xu, MD, Meghamsh Kanuparthy, MD, Akshay Malhotra, M. Ruhul Abid, MD, PhD, Frank W. Sellke, MD, FACS
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 49-63 (2024)
Objective: Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Patients with advanced coronary artery disease who are not eligible for endovascular or surgical revascularization have limited options. Extracellular ve
Externí odkaz:
https://doaj.org/article/5f4afdcb756649dca1e6ceb06d9b4d02
Autor:
Mohamed Sabra, MD, Sharif A. Sabe, MD, Dwight D. Harris, MD, Cynthia M. Xu, MD, Mark Broadwin, MD, Krishnah G. Bellam, BS, Debolina Banerjee, MD, M. Ruhul Abid, MD, PhD, Frank W. Sellke, MD
Publikováno v:
JTCVS Open, Vol 16, Iss , Pp 419-428 (2023)
Background: Coronary artery disease remains a leading cause of death worldwide. Bone mesenchymal stem cell–derived extracellular vesicles (EVs) have shown promise in the setting of myocardial ischemia. Furthermore, the properties of the EVs can be
Externí odkaz:
https://doaj.org/article/1abe4224b2784819a9eb84c47a031940
Autor:
Dwight D. Harris, MD, Sharif A. Sabe, MD, Mohamed Sabra, MD, Cynthia M. Xu, MD, Akshay Malhotra, Mark Broadwin, MD, Debolina Banerjee, MD, M. Ruhul Abid, MD, PhD, Frank W. Sellke, MD
Publikováno v:
JTCVS Open, Vol 15, Iss , Pp 220-228 (2023)
Objective: Limited treatments exist for nonoperative chronic coronary artery disease. Previously, our laboratory has investigated extracellular vesicle (EV) therapy as a potential treatment for chronic coronary artery disease using a swine model and
Externí odkaz:
https://doaj.org/article/38099fd14f5e4cf1bade6d4d8db6a084